Literature DB >> 17434922

Cancer genomics: integrating form and function.

So Young Kim1, William C Hahn.   

Abstract

The sequencing of the human genome has formed the foundation with which to develop technologies and reagents to perform true genome-scale biological studies. In particular, the development and increasing application of these high-throughput genome-scale technologies have fundamentally altered the way one can approach the analysis of cancer. It is now possible to imagine studies that interrogate the structure, expression and function of every gene in a comprehensive, highly parallel fashion, permitting the development of multidimensional, global views of cancer. In this review, we focus on recent advances in the application of genomic strategies to the study of cancer, with an emphasis on functional genomics and the prospects for integrating the knowledge gained from these approaches to further develop our understanding of cancer and design better therapeutic strategies.

Entities:  

Mesh:

Year:  2007        PMID: 17434922     DOI: 10.1093/carcin/bgm086

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  8 in total

Review 1.  Biomarkers for colorectal cancer.

Authors:  Takuji Tanaka; Mayu Tanaka; Takahiro Tanaka; Rikako Ishigamori
Journal:  Int J Mol Sci       Date:  2010-09-13       Impact factor: 5.923

2.  Epstein-Barr virus-transformation of B-cell lines in ovarian cancer patients: feasibility of genomic storage for unlimited use.

Authors:  Sun-Young Kong; Sokbom Kang
Journal:  J Gynecol Oncol       Date:  2009-12-28       Impact factor: 4.401

3.  Identification of urinary modified nucleosides and ribosylated metabolites in humans via combined ESI-FTICR MS and ESI-IT MS analysis.

Authors:  Dino Bullinger; Richard Fux; Graeme Nicholson; Stefan Plontke; Claus Belka; Stefan Laufer; Christoph H Gleiter; Bernd Kammerer
Journal:  J Am Soc Mass Spectrom       Date:  2008-06-28       Impact factor: 3.109

Review 4.  Genomic screening with RNAi: results and challenges.

Authors:  Stephanie Mohr; Chris Bakal; Norbert Perrimon
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

5.  DNA aptamers as molecular probes for colorectal cancer study.

Authors:  Kwame Sefah; Ling Meng; Dalia Lopez-Colon; Elizabeth Jimenez; Chen Liu; Weihong Tan
Journal:  PLoS One       Date:  2010-12-10       Impact factor: 3.240

6.  Human cancer classification: a systems biology- based model integrating morphology, cancer stem cells, proteomics, and genomics.

Authors:  Halliday A Idikio
Journal:  J Cancer       Date:  2011-02-22       Impact factor: 4.207

Review 7.  Genomic and oncoproteomic advances in detection and treatment of colorectal cancer.

Authors:  Seamus M McHugh; Jill O'Donnell; Peter Gillen
Journal:  World J Surg Oncol       Date:  2009-04-01       Impact factor: 2.754

8.  Genetic interactions: the missing links for a better understanding of cancer susceptibility, progression and treatment.

Authors:  Christopher A Maxwell; Víctor Moreno; Xavier Solé; Laia Gómez; Pilar Hernández; Ander Urruticoechea; Miguel Angel Pujana
Journal:  Mol Cancer       Date:  2008-01-10       Impact factor: 27.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.